Transgenic animals as new approaches in pharmacological studies

Annual Review of Pharmacology and Toxicology

Volumn 37, Issue , 1997, Pages 119-141

  Wei, Li Na ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

animal models; ES technology; gene targeting; pronuclear injection

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CANCER; CARDIOVASCULAR SYSTEM; ENDOCRINE SYSTEM; GENE TARGETING; MODEL; NERVOUS SYSTEM; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; TOXICOLOGY; TRANSGENIC ANIMAL;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0030915848     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.37.1.119     Document Type: Article

References (110)

1. Jaenisch R, Mintz B. 1974. Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. Proc. Natl. Acad. Sci. USA 71:1250-54
2. Jaenisch R, Fan H, Kroker B. 1975. Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukeinogenesis in the adult animal. Proc. Natl. Acad. Sci. USA 72:4008-12
3. Jaenisch R. 1976. Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc. Natl. Acad. Sci. USA 73:1260-64
4. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH. 1980. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. USA 77:7380-84
5. Brinster RL, Chen HY, Trumbauer M, Senear AW, Warren R, et al. 1981. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27:223-31
6. Costantini F, Lacy E. 1981. Introduction of a rabbit beta-globin gene into the mouse germ line. Nature 294:92-94
7. Harbers K, Jahner D, Jaenisch R. 1981. Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. Nature 293:540-42
8. Wagner EF, Stewart TA, Mintz B. 1981. The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc. Natl. Acad. Sci. USA 78:5016-20
9. Wagner TE, Hoppe PC, Jallick JD, Scholl DR, Hodinka RL, et al. 1981. Microinjection of a rabbit beta-globin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc. Natl. Acad. Sci. USA 78:6376-80
10. Gardner RL. 1968. Mouse chimeras obtained by the injection of cells into the blastocyst. Nature 220:596-97
11. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78:7634-38
12. Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-56
13. Bradley A, Evans M, Kaufman MH, Robertson E. 1984. Formation of germline chimeras from embryo-derived teratocarcinoma cell lines. Nature 309:255-56
14. Gossler A, Doetschman T, Korn R, Serfling E, Kemler R. 1986. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83:9065-69
15. Thomas KR, Capecchi MR. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503-12
16. Capecchi MR. 1989. The new mouse genetics: altering the genome by gene targeting. Trends Gen. 5:70-76
17. Schwartzberg PL, Goff SP, Robertson EJ. 1989. Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246:799-803
18. Thompson S, Clarke AR, Pow AM, Hooper ML, Melton DW. 1989. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56:313-21
19. Brandon EP, Idzerda RL, McKnight GS. 1995. Targeting the mouse genome: a compendium of knockouts (part I). Curr. Biol. 5:625-34
20. Brandon EP, Idzerda RL, McKnight GS. 1995. Targeting the mouse genome: a compendium of knockouts (part II). Curr. Biol. 5:758-65
21. Brandon EP, Idzerda RL, McKnight GS. 1995. Targeting the mouse genome: a compendium of knockouts (part III). Curr. Biol. 5:873-81
22. Hogan B, Beddington R, Costantini F, Lacy E. 1994. Manipulating the Mouse Embryo, A Laboratory Manual. pp. 115-87. New York: Cold Spring Harbor Lab Press. 2nd ed.
23. Berget SM. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270: 2411-14
24. Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL. 1983. Metallothionein-human GH fusion genes stimulate growth of mice. Science 222:809-14
25. Shockett PE, Schatz DG. 1996. Diverse strategies for tetracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. USA 93:5173-76
26. Braselmann S, Graninger P, Busslinger M. 1993. A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. USA 90: 1657-61
27. No D, Yao T-P, Evans RM. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93:3346-51
28. Furth PA, St. Onge L, Boger H, Gruss P, Gossen M, et al. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91:9302-6
29. Wu Z, Xie Y, Bucher NLR, Farmer SR. 1995. Conditional ectopic expression of C/EBPß in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev. 9:2350-63
30. Izant JG, Weintraub H. 1985. Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA. Science 229:345-51
31. Kim SK, Wold BJ. 1985. Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA. Cell 42:129-38
32. McGarry TJ, Lindquist S. 1986. Inhibition of heat shock protein synthesis by heat-inducible antisense RNA. Proc. Natl. Acad. Sci. USA 83:399-403
33. Pepin M-C, Pothier F, Barden N. 1992. Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene. Nature 355:725-28
34. Freedman MR, Stern JS, Reaven GM, Mondon CE. 1986. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats. Horm. Metab. Res. 18:196-98
35. Breitman ML, Clapoff S, Rossant J, Tsui L-C, Glode LM, et al. 1987. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 238:1563-65
36. Wallace H, McLaren K, al-Shawi R, Bishop JO. 1994. Consequences of thyroid hormone deficiency induced by the specific ablation of thyroid follicle cells in adult transgenic mice. J. Endocrinol. 143:107-20
37. Breitman ML, Rombola H, Maxwell IH, Klintworth GK, Bernstein A. 1990. Genetic ablation in transgenic mice with an attenuated diphtheria toxin A gene. Mol. Cell. Biol. 10:474-79
38. Damm K, Heyman RA, Umesono K, Evans RM. 1993. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA. 90:2989-93
39. Saitou M, Sugai S. Tanaka T, Shimouche K, Fuchs E, et al. 1995. Inhibition of skin development by targeted expression of a dominant negative retinoic acid receptor. Nature 374:159-62
40. Sanes JR, Rubenstein JL, Nicolas JF. 1986. Use of a recombinant retrovirus to study postimplantation cell lineage in mouse embryos. EMBO J. 5:3133-42
41. Wei L-N, Chen G-J, Chu Y-S, Tsao J-L, Nguyen-Huu MC. 1991. A 3 kb sequence from the mouse cellular retinoic acid binding protein gene upstream region mediates spatial and temporal lacZ expression in transgenic mouse embryos. Development 112:847-54
42. Wei L-N, Chang L. 1996. Promoter and upstream regulatory activities of the mouse cellular retinoic acid-binding protein-I gene. J. Biol. Chem. 271:5073-78
43. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, et al. 1988. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688-90
44. Robertson EJ. 1987. Teratocarcinomas and Embryonic Stem Cells, A Practical Approach. pp. 71-112. Washington, DC: IRL
45. Magin TM, McWhir J, Melton DW. 1992. A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency. Nucleic Acid Res. 20:3795-96
46. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424-28
47. Hasty P, Ramirez SR, Krumlauf R, Bradley A. 1991. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350:243-46
48. Valancius V, Smithies O. 1991. Testing an "In-Out" targeting procedure for making subtle genomic modifications in mouse embryonic stems. Mol. Cell. Biol. 11:1402-8
49. Geisterfer-Lowrance AAT, Christe M, Conner DA, Ingwall JS, Schoen FJ, et al. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science 272:731-34
50. Askew GR, Doetschman T, Lingrel JB. 1993. Site-directed point mutations in embryonic stem cells: a gene-targeting tag- and-exchange strategy. Mol. Cell. Biol. 13:4115-24
51. Wu H, Liu X, Jaenisch R. 1994. Double replacement: strategy for efficient introduction of subtle mutations into the murine Colla-1 gene by homologous recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA 91:2819-23
52. Bronson S, Smithies O. 1994. Altering mice by homologous recombination using embryonic stem cells. J. Biol. Chem. 269:27155-58
53. Rossant J, Nagy A. 1995. Genome engineering: the new mouse genetics. Nat. Med. 1:592-94
54. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, et al. 1995. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
55. Fong G-H, Rossant J, Gertsenstein M, Breitman ML. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
56. Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL. 1995. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269:679-82
57. Kuhn R, Schwenk F, Aguet M, Rajewsky K. 1995. Inducible gene targeting in mice. Science 269:1427-29
58. Sobol RW, Horton JK, Ku;hn R, Gu H, Singhal RK, et al. 1996. Requirement of mammalian DNA polymerase-β in base-excision repair. Nature 379:183-86
59. Golic KG, Lindquist S. 1989. The FLP recombinase of yeast catalyzes site-specific recombination in the Drosophila genome. Cell 59:499-509
60. O'Gorman S, Fox DT, Wahl GM. 1991. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251:1351-55
61. Sauer B, Henderson N. 1989. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acid Res. 17:147-61
62. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. 1994. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265:103-6 63. Ramirez-Solis R, Liu P, Bradley A. 1995. Chromosome engineering in mice. Nature 378:720-24
63. Ramirez-Solis R, Liu P, Bradley A. 1995. Chromosome engineering in mice. Nature 378:720-24
64. Houdebine LM. 1995. The production of pharmaceutical proteins from the milk of transgenic animals. Reprod. Nutr. Dev. 35:609-17
65. Ohkubo H, Kawakami H, Kakehi Y, Takumi T, Arai H, et al. 1990. Generation of transgenic mice with elevated blood pressure by introduction of rat renin and angiotensinogen genes. Proc. Natl. Acad. Sci. USA 87:5153-57
66. Ganten D, Schmidt S, Paul M. 1994. Genetics of primary hypertension. J. Cardiovasc. Pharmacol. 24:S45-50
67. Wagner J, Thiele F, Ganten D. 1996. The renin-angiotensin system in transgenic rats. Pediatr. Nephrol. 10:108-12
68. Mullins JJ, Peters J, Ganten D. 1990. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-44
69. Sander M, Bader M, Djavidani B, Maser-Gluth C, Vecsei P. 1992. The role of the adrenal gland in the hypertensive transgenic rats TGR(mREN2)27. Endocrinology 131:807-14
70. Ganten D, Wagner J, Zeh K, Bader M, Michel JB, et al. 1992. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc. Natl. Acad. Sci. USA 89:7806-10
71. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, et al. 1995. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-48
72. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, et al. 1995. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature 377:748-50
73. Herz J, Willnow TE. 1995. Lipoprotein and receptor interactions in vivo. Curr. Opin. Lipidol. 6:97-103
74. Tall AR. 1995. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J. Intern. Med. 237:5-12
75. 2-Adrenergic receptor. Science 264:582-86
76. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 91:10109-13
77. sα protein in the hearts of transgenic mice. J. Clin. Invest. 95:1676-83
78. Koch WJ, Rockman HA, Samama P, Hamilton R, Bond RA, et al. 1995. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268:1350-53
79. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, et al. 1991. Tissue specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266:24613-20
80. 3-adrenergic receptor gene. J. Biol. Chem. 270:29483-92
81. Mayford M, Abel T, Kandel ER. 1995. Transgenic approaches to cognition. Curr. Opin. Neurobiol. 5:141-48
82. Lucas JJ, Hen R. 1995. New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol. Sci. 16:246-52
83. Kauppinen RA, Alhonen LI. 1995. Transgenic animals as models in the study of the neurobiological role of polyamines. Prog. Neurobiol. 47:545-63
84. Chen C, Rainnie DG, Greene RW, Tonegawa S. 1994. Abnormal fear response and aggressive behavior in mutant mice deficient for α-calcium-calmodulin kinase II. Science 266:291-94
85. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-85
86. Irikura K, Huang PL, Ma J, Lee WS, Dalkara T, et al. 1995. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc. Natl. Acad. Sci. USA 92:6823-27
87. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, et al. 1994. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875-78
88. 2c serotonin receptors. Nature 374:542-46
89. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, et al. 1995. Failure of post-synaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377:232-36
90. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, et al. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:1763-66
91. Liu X, Ernfors P, Wu H, Jaenisch R. 1995. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 375:238-41
92. Zhou Z-Y, Quaife CJ, Palmiter RD. 1995. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374:640-43
93. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, et al. 1995. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374:65-67
94. Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S. 1994. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76:427-37
95. Conquet F, Bashir ZI, Davies CH, Daniel H, Ferraguti F, et al. 1994. Motor deficit and impairment of synaptic plasticity in mice lacking mGluRl. Nature 372:237-43
96. Dougherty WG, Parks TD. 1996. Transgenes and gene suppression: telling us something new? Curr. Opin. Cell Biol. 7:399-405
97. Hamernik DL. 1995. Molecular biology of gonadotrophins. J. Reprod. Fertil. Suppl. 49:257-69
98. Samoni M. 1994. Transgenic animals in male reproduction research. Exp. Clin. Endocrinol. 102:419-33
99. Barden N. 1994. Corticosteroid receptor modulation in transgenic mice. Ann. N. Y. Acad. Sci. 746:89-98
100. Kastner P, Mark M, Chambon P. 1995. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life. Cell 83:859-69
101. Wei L-N, Lee C-H, Chang S-L, Chu Y-S. 1992. Pathogenesis in transgenic mice expressing bovine cellular retinoic acid-binding protein. Devel. Growth Differ. 34:479-88
102. Gorry P, Lufkin T, Dierich A, Rochette-Egly C, Decimo D, et al. 1994. The cellular retinoic acid binding protein I is dispensable. Proc. Natl. Acad. Sci. USA 91:9032-36
103. deBruijn DRH, Oerlemans F, Hendriks W, Baats E, Ploemacher R, et al. 1994. Normal development, growth and reproduction in cellular retinoic acid binding protein I (CRABPI) null mutant mice. Differentiation 58:141-48
104. Christofori G, Hanahan D. 1994. Molecular dissection of multi-stage tumorigenesis in transgenic mice. Sem. Cancer Biol. 5:3-12
105. Thomas H, Balkwill F. 1995. Assessing new anti-tumor agents and strategies in oncogene transgenic mice. Cancer Metastasis Rev. 14:91-95
106. Viney JL. 1995. Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev. 14:77-90
107. Brusick D. 1995. Applications for transgenic animals in toxicology. Arch. Toxicol. Suppl. 17:23-34
108. Mirsalis JC, Monforte JA, Winegar RA. 1995. Transgenic Animal Models for Detection of In Vivo Mutations. Annu. Rev. Pharmacol. Toxicol. 35:145-64
109. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SST, et al. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722-26
110. Mark M, Lohnes D, Mendelsohn C, Dupe V, Vanesch JL, et al. 1995. Roles of retinoic acid receptors and of Hox genes in the patterning of the teeth and of the jaw skeleton. Int. J. Dev. Biol. 39:111-21